ORAL CAVITY CANCER
Clinical trials for ORAL CAVITY CANCER explained in plain language.
Never miss a new study
Get alerted when new ORAL CAVITY CANCER trials appear
Sign up with your email to follow new studies for ORAL CAVITY CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for Tough-to-Treat head and neck cancer
Disease control CompletedThis study tested a combination of two drugs, pembrolizumab and cetuximab, in 78 people with advanced head and neck cancer that had returned or spread. The goal was to see if the combination could shrink tumors or slow the disease. Participants were grouped based on whether they …
Matched conditions: ORAL CAVITY CANCER
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 22, 2026 12:09 UTC
-
Immunotherapy boosts standard treatment for head and neck cancer in early trial
Disease control CompletedThis early-phase trial tested whether adding the immunotherapy drug pembrolizumab to standard chemoradiation is safe and effective for people with advanced head and neck cancer. 59 participants received pembrolizumab before, during, and after their regular treatment. The goal was…
Matched conditions: ORAL CAVITY CANCER
Phase: PHASE1 • Sponsor: Sanford Health • Aim: Disease control
Last updated Jun 18, 2026 11:53 UTC